CORT Corcept Therapeutics Incorporated

USD 51.40 0.00 ( 0.00)%
Icon

Corcept Therapeutics Incorporated (CORT) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 51.40

0.00 (0.00)%

USD 6.37B

2.46M

USD 58.40(+13.62%)

N/A

Icon

CORT

Corcept Therapeutics Incorporated (USD)
COMMON STOCK | NSD
USD 51.40
0.00 ( 0.00)%

Corcept Therapeutics Incorporated (CORT) Stock Forecast

Show ratings and price targets of :
USD 58.40
(+13.62%)

Based on the Corcept Therapeutics Incorporated stock forecast from 3 analysts, the average analyst target price for Corcept Therapeutics Incorporated is USD 58.40 over the next 12 months. Corcept Therapeutics Incorporated’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Corcept Therapeutics Incorporated is Slightly Bullish , which is based on 9 positive signals and 4 negative signals. At the last closing, Corcept Therapeutics Incorporated’s stock price was USD 51.40. Corcept Therapeutics Incorporated’s stock price has changed by -7.22% over the past week, -10.67% over the past month and +56.90% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...